Isabell Remus
Biopharmaceuticals,Europe,Sandoz
Biography
Isabell Remus currently serves as Head, Biopharmaceuticals Europe overseeing the commercialization for the second largest, and rapidly growing, biosimilars market. Under her leadership, Sandoz region Europe expanded its market leadership and launched five biosimilars; increasing the total number of Sandoz biosimilars on market to eight. She is a member of the Biopharma Executive Committee as well as the Region Europe Leadership Team. Isabell also chairs the Biosimilar Medicines Group, a sector group of Medicines for Europe. She has a breadth of proven leadership experience across global brand management, market access and portfolio strategy over a variety of therapeutic areas including immunology, oncology, and more.
Abstract
Abstract : The role of biosimilars in fostering sustainable cancer care